What is the difference between negotiating PBM rebates versus actually managing pharmacy trend for employers?
Answered at 22:01 in Episode 66 - Designing the Future PBM Model with Judi Health · HR Benecast
What is the difference between negotiating PBM rebates versus actually managing pharmacy trend for employers?
Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions. Nick Van Hook emphasizes that employers must marry drug costs and rebate negotiations with active population management—including formulary strategies, prior authorization, and preventing excess days supply—because discounts alone do not control trend if more units are being pushed out the door or if steerage occurs toward higher-cost products to meet rebate targets.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions.
Nick Van Hook, Senior Vice President of National Business Development at Judy Health · Episode 66 - Designing the Future PBM Model with Judi Health · HR Benecast · answer at 22:01
Key takeaways
- Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions.
Quote to remember
“We wanted to get back to what the core roots of PBM was when they started, and that was be the best administrator, a fee for service organization that had arm's length relationships throughout the supply chain.”
— Nick Van Hook
The full answer · about 3 min
Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions. Nick Van Hook emphasizes that employers must marry drug costs and rebate negotiations with active population management—including formulary strategies, prior authorization, and preventing excess days supply—because discounts alone do not control trend if more units are being pushed out the door or if steerage occurs toward higher-cost products to meet rebate targets.
Key facts
- Over 15 years in the pharmacy benefit space (Nick Van Hook's career history)
- Over 7 years with Judy Health (Nick Van Hook's tenure)
- 9 years since Judy Health's inception
- 12 or 13 states with minimum reimbursement requirements based on NADAC plus dispensing fee
- Specialty spend represents over half of total pharmacy spend for many clients
People, companies and topics mentioned
More answers from this episode
- 3:23What is Judy Health's core technology platform Judy designed to solve in pharmacy benefit management?
- 13:00How does Judy Health's cost-plus transparent PBM model address fiduciary concerns raised by recent PBM lawsuits?
- 16:00What approach does Judy Health take to biosimilar formulary strategy compared to traditional PBMs?
- 19:03How does Judy Health manage specialty drug spending beyond pricing to control total pharmacy costs?
- 25:40How is Judy Health prepared to scale while maintaining customer satisfaction as it grows?